AxoGen Investor Relations Material
Latest events
Q2 2025
AxoGen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AxoGen Inc
Access all reports
AxoGen Inc develops and markets surgical solutions for peripheral nerve injuries. The company provides nerve grafts, connectors, and related products used by surgeons to repair damaged or severed nerves. It serves hospitals and surgical centers across the United States. The company is headquartered in Alachua, Florida, and its shares are listed on the NASDAQ.
Key slides for AxoGen Inc
Q2 2025
AxoGen Inc
Investor Day 2025
AxoGen Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
AXGN
Country
🇺🇸 United States